AVOCENT CORP 4
4 · AVOCENT CORP · Filed Feb 9, 2004
Insider Transaction Report
Form 4
AVOCENT CORPAVCT
DAMBRACKAS WILLIAM A
Exec VP, Advanced Technology
Transactions
- Award
Common Stock
2004-02-05+20,000→ 20,000 totalExercise: $40.98From: 2004-02-05Exp: 2014-02-05→ Common Stock (20,000 underlying)
Holdings
- 1,698
Common Stock
- 30,000
Options (rights to buy)
Exercise: $27.25From: 2003-03-07Exp: 2013-03-07→ Common Stock (30,000 underlying) - 4,500
Options (rights to buy)
Exercise: $22.36From: 2001-05-25Exp: 2011-05-25→ Common stock (4,500 underlying) - 31,500
Options (rights to buy)
Exercise: $29.31From: 2001-01-03Exp: 2011-01-03→ Common Stock (31,500 underlying) - 9,000
Options (rights to buy)
Exercise: $21.77From: 2002-04-15Exp: 2012-04-15→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]Grant date, 15% vests every six months for the first 12 months, 6.25% vests quarterly for the following 24 months and 5% vests quarterly for the remaining 12 months.
- [F2]Grant date, 25% vests after 6 months and in 10 equal quarterly installments thereafter.